JeffreyS.MillerDO

PubMed

• 35 citations
  Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
  Melissa M. Berrien-Elliott, Michelle Becker-Hapak, Amanda F. Cashen, Miriam T. Jacobs, Pamela Wong, Mark P. Foster, Ethan McClain, Sweta Desai, Patrick Pence, Sarah Co...> ;Blood. 2021 Nov 19
• Activation status dictates the function of unlicensed natural killer cells in mice and humans
  Ethan G. Aguilar, Cordelia Dunai, Sean J. Judge, Anthony E. Zamora, Lam T. Khuat, Logan V Vick, Craig P Collins, Kevin Stoffel, Maite Alvarez, Isabel Barao, Jeffrey S....> ;Blood Advances. 2021 Oct 26
• 1 citations
  Novel Cell and Immune Engagers in Optimizing Tumor- Specific Immunity Post-Autologous Transplantation in Multiple Myeloma.
  Murali Janakiram, Nivedita Arora, Veronika Bachanova, Jeffrey S. Miller> ;Transplantation and Cellular Therapy. 2021 Oct 8
• 71 citations
  Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy
  Karrune Woan, Hansol Kim, Ryan Bjordahl, Zachary Davis, Svetlana Gaidarova, John Goulding, Brian Hancock, Sajid Mahmood, Ramzey Abujarour, Hongbo Wang, Katie Tuininga,...> ;Cell Stem Cell. 2021 Sep 14
• Putting On the Gas and Taking Off the Brakes: A Novel Combinatorial Strategy to Enhance Tumor-Infiltrating Lymphocytes.
  Martin Felices, Jeffrey S. Miller> ;Cancer Immunology Research. 2021 Sep 7
• 16 citations
  A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer
  Daniel A. Vallera, Felix Oh, Behiye Kodal, Peter Hinderlie, Melissa A. Geller, Jeffrey S. Miller, Martin Felices> ;Cancers. 2021 Aug 8
• 24 citations
  Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy.
  Shee Kwan Phung, Jeffrey S. Miller, Martin Felices> ;Molecular Diagnosis & Therapy. 2021 Jul 29
• 14 citations
  Activation of ADAM17 by IL-15 Limits Human NK Cell Proliferation
  Hemant K. Mishra, Kate Dixon, Nabendu Pore, Martin Felices, Jeffrey S. Miller, Bruce Walcheck> ;Frontiers in Immunology. 2021 Jul 22
• 7 citations
  Infusion reactions in natural killer cell immunotherapy: a retrospective review
  Tewodros Mamo, Shelly M. Williams, Stephanie Kinney, Katelyn M. Tessier, Todd E. DeFor, Sarah Cooley, Jeffrey S. Miller, David H. McKenna> ;Cytotherapy. 2021 Jul 1
• 6 citations
  Following Transplantation for Acute Myelogenous Leukemia, Donor KIR Cen B02 Better Protects against Relapse than KIR Cen B01.
  Lisbeth A. Guethlein, Niassan Beyzaie, Neda Nemat-Gorgani, Tao Wang, Vidhyalakshmi Ramesh, Wesley M. Marin, Jill A. Hollenbach, Johannes Schetelig, Stephen R. Spellman...> ;Journal of Immunology. 2021 Jun 11
• Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL (Cancer Immunology, I...
  Sarah B. Reusing, DA Vallera, Angela R. Manser, Titus Watrin, Sanil Bhatia, Martin Felices, Jeffrey S. Miller, Markus Uhrberg, Florian Babor> ;Cancer Immunology, Immunotherapy. 2021 Jan 1
• 8 citations
  Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up
  Erica D. Warlick, Todd E. DeFor, Nelli Bejanyan, Shernan G. Holtan, Margaret L. MacMillan, Bruce R. Blazar, Kathryn E. Dusenbery, Mukta Arora, Veronika Bachanova, Sara...> ;Biology of Blood and Marrow Transplantation. 2019 Jan 1
• 17 citations
  Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics
  Fatma Keklik, Ezzideen Barjes Alrawi, Qing Cao, Nelli Bejanyan, Armin Rashidi, Aleksandr Lazaryan, Patrick G. Arndt, H. Erhan Dincer, Veronika Bachanova, Erica D. Warl...> ;Haematologica. 2018 Dec 1
• 144 citations
  HVAD: The ENDURANCE Supplemental Trial.
  Carmelo A. Milano, Joseph G. Rogers, Antone Tatooles, Geetha Bhat, Mark S. Slaughter, Emma J. Birks, Nahush A. Mokadam, Claudius Mahr, Jeffrey S. Miller, David W. Mark...> ;JACC. Heart Failure. 2018 Jul 11
• 73 citations
  161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
  Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd Lenvik, Peter Hinderlie, Julie M. Curtsinger, Erica D. Warlick, Stephen R. Spellman, Bruce R. Bla...> ;Blood Advances. 2018 Jun 26
• 8 citations
  Repeat Robotic Endoscopic Mitral Valve Operation: A Safe and Effective Strategy.
  Douglas A. Murphy, Emmanuel Moss, Jeffrey Miller, Michael E. Halkos> ;The Annals of Thoracic Surgery. 2018 Jun 1
• 46 citations
  Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells
  Kristina S. Burrack, Matthew A. Huggins, Emily Taras, Philip Dougherty, Christine Henzler, Rendong Yang, Sarah Alter, Emily K. Jeng, Hing C. Wong, Martin Felices, Fran...> ;Immunity. 2018 Apr 17
• 116 citations
  Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML
  Andreas T. Björklund, Mattias Carlsten, Ebba Sohlberg, Lisa L. Liu, Trevor Clancy, Mohsen Karimi, Sarah Cooley, Jeffrey S. Miller, Monika Klimkowska, Marie Schaffer, E...> ;Clinical Cancer Research. 2018 Apr 15
• 265 citations
  ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
  John Wrangle, Vamsidhar Velcheti, Manish R. Patel, Elizabeth Garrett-Mayer, Elizabeth G. Hill, James G. Ravenel, Jeffrey S. Miller, Mohammad Farhad, Kate Anderton, Kat...> ;The Lancet. Oncology. 2018 May 1
• 41 citations
  A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
  Todd A. Fehniger, Jeffrey S. Miller, Robert K. Stuart, Sarah Cooley, Amandeep Salhotra, Julie M. Curtsinger, Peter Westervelt, John F. DiPersio, Timothy Mark Hillman, ...> ;Biology of Blood and Marrow Transplantation. 2018 Aug 1
• 87 citations
  Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
  Sarah Cooley, Peter Parham, Jeffrey S. Miller> ;Blood. 2018 Mar 8
• 1 citations
  Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.
  Armin Rashidi, Ryan Shanley, Sophia Yohe, Bharat Thyagarajan, Julie M. Curtsinger, Claudio Anasetti, Edmund K. Waller, Jeffrey S. Miller, Bruce R. Blazar, Daniel J. We...> ;Bone Marrow Transplantation. 2018 Mar 7
• 67 citations
  Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells.
  Veronika Bachanova, Dhifaf Sarhan, Todd E. DeFor, Sarah Cooley, Angela Panoskaltsis-Mortari, Bruce R. Blazar, Julie M. Curtsinger, Linda J. Burns, Daniel J. Weisdorf, ...> ;Cancer Immunology, Immunotherapy. 2018 Mar 1
• 116 citations
  A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
  Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish R. Patel, Holbrook E Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary L. Disis, Judith...> ;Clinical Cancer Research. 2017 Dec 4
• 23 citations
  In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines
  Keli L. Hippen, Roddy S. O’Connor, Amanda M. Lemire, Asim Saha, Eric A. Hanse, N. C. Tennis, Sarah C. Merkel, Ameeta Kelekar, James L. Riley, Bruce L. Levine, Carl H. ...> ;American Journal of Transplantation. 2017 Dec 1
• Join now to see all